Sold off Krsnaa, the problem here in hind-sight is that govt doctors/staff (radiologists/pathologists/technicians) never get fired, so apparently only new launched facilities are being covered by Krsnaa. Also it is not easy to become a B2C player, there are Dr Lal labs every 300 m and still many more players. Their radiology machines are very expensive and tendering means low prices.
Bought Diamines & Chemicals Ltd, its sales are at peak margins and peak revenues, so appears cheap. They are moving forward after a ~8 year delay on their capex, primary use is in detergents, drugs, lubes, paints. Margins can vary quite a bit but european production may remain low to support it, just guessing here. Capex will be total 7x current level, perhaps better product mix too, land and buildings are present, equipment is in progress, more guessing here. No info shared by management except 90 minute interaction from AGM. Perhaps 1-2 years before capex comes fully online, sales is another matter 
Had bought Diamines before, held it for 6 months between Feb-Sept 2020, avg buy 220, avg sell 430. Good call since it did much worse in 2021, now a big reversal in 2022 which is a risk going forward. They had clearance which was going to expire after doing nothing for 7 years, they renewed it in 2022 for 4 more years, IIRC. Rough guess from EC doc is 10x capacity expansion but also hear that revenues may only be 4x from here. As base case it will easily do if management performs in timely fashion. Peers such as Balalji and Alkyl amines have done 4x since 2020-21 since it seems that Chinese supplies were being stopped by shipping issues and duties.
Added little money where prices are below buy avg, Best agro and Ugro.
DISCLAIMER : this is not investment advice, I am not a sebi registered investment advisor.
Please do your due diligence before investing.
| Subscribe To Our Free Newsletter |
